• USA

  • Main slide - structure search -green

  • deal-of-the-week-pic-with-click-here

Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.

 

 

World ADC 2018

Booth # 39
November 12-15, 2018
Marriott Marquis & Marina
San Diego, CA

 

PEGS 2018 Europe 

Booth # 114
November 12-16, 2018
 
Lisbon Congress Center
Lisbon, Portugal